NSPR

Conviction 0HealthcareScan · Fri, Jun 26, 2026

Bullish marubozu

NSPR$0.7024+7.24%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 149.78K

Mar 27Apr 15May 4May 20Jun 9Jun 26

InspireMD, Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.inspiremd.com ↗

Price0.7024

Change+7.24%

Gap-0.76%

Rel volume0.37×

Avg volume154.62K

Avg $ vol124.56K

SMA 200.7949

SMA 501.01

SMA 2001.69

Price vs 50-30.19%

Price vs 200-58.42%

MA stackbearish

50/200 cross—

Supertrenddown · 0.9169

RSI (14)33

MACD hist0.01

MACD crossbull · 3d

Stoch %K / %D19 / 9

ADX (14)29

+DI / −DI10 / 21

RSI divergence—

MACD divergence—

ATR %+11.85%

ADR %11.00%

52w high2.79

52w low0.6550

From 52w high-74.82%

Above 52w low+7.24%

New 52w highNo

SqueezeOff

Bollinger width54.25%

%B0.29

Donchian pos14.54%

Donchian high1.04

Donchian low0.6450

AVWAP (52w high)1.51

vs AVWAP high-53.50%

AVWAP (52w low)0.6813

vs AVWAP low+3.10%

OBV trendFlat

Chaikin MF (20)-0.46

Today vs 20d0.37×

Avg vol (14d)149.78K

Avg vol (20d)154.62K

Avg $ vol (20d)124.56K

Market cap—

RS 3m (vs SPY)-74.79%

RS 6m (vs SPY)-76.33%

RS line new highNo

Trend template0/8

Technical rank6.7

1 week-1.07%

1 month-20.14%

3 months-59.40%

6 months-67.33%

1 year-68.64%

YTD-62.24%

P/E-0.65

P/B0.73

P/S3.54

P/FCF-0.86

EPS-0.7600

Div yield—

ROE-111.85%

ROA-86.39%

Debt/Eq0.09

Current5.15

EV/EBITDA-0.49

Gross margin29.50%

Net margin-543.33%

Rev growth28.11%

EPS growth-52.43%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value24.21M

Revenue3.4M

Net income-13.69M

Gross profit687K

Free cash flow-36.77M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out46.84M

Employees127

ListedFri, Aug 22, 1997

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank6.7 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish marubozu

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NSPR

All disclosures →

No recent disclosed trades by Congress in NSPR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NSPR · 1 buy · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Stuka Paul Director · Common Stock · 2026-05-27	Other	—	—	2026-05-27	2026-05-29
Stuka Paul Director · Common Stock · 2026-05-27	Buy	20K	$18K	2026-05-27	2026-05-29
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2026-05-19	Sell	22.78K	$23K	2026-05-19	2026-05-21
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2026-02-02	Sell	2.94K	$5K	2026-02-02	2026-05-21
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2025-05-30	Sell	7.19K	$18K	2025-05-30	2026-05-21
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2025-05-29	Sell	3.76K	$9K	2025-05-29	2026-05-21
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2025-05-27	Sell	1.57K	$4K	2025-05-27	2026-05-21
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2025-05-23	Sell	2.48K	$6K	2025-05-23	2026-05-21
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2025-02-25	Sell	10K	$37K	2025-02-25	2026-05-21
Gleason Shane Thomas Chief Commercial Officer · Common Stock · 2025-02-04	Sell	5.13K	$13K	2025-02-04	2026-05-21

SEC filings

EDGAR filings in NSPR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.